STTK NASDAQ
Shattuck Labs, Inc.
1W: -1.2%
1M: -10.3%
3M: -14.6%
YTD: +55.5%
1Y: +200.5%
3Y: +312.1%
5Y: -70.8%
$5.77
+0.23 (+4.15%)
Weekly Expected Move ±10.7%
$4
$5
$5
$6
$7
Credit Risk of going bust: lower than 74% of companies Debt: 0.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Shattuck Labs, Inc. would be worth roughly what it owes.
Total debt $2.7M against a stock market value of $579.1M.
Distance to default 8.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $900K (short-term plus half of long-term), stock volatility 75.8%; Altman Z'' 20.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Shattuck Labs, Inc. would be worth roughly what it owes.
Total debt $2.7M against a stock market value of $579.1M.
Distance to default 8.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $900K (short-term plus half of long-term), stock volatility 75.8%; Altman Z'' 20.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$579.1M
52W Range1.72-8.33
Volume699,500
Avg Volume1,332,879
Beta1.10
Dividend—
Analyst Ratings
Company Info
CEOTaylor H. Schreiber
Employees40
SectorHealthcare
IndustryBiotechnology
IPO Date2020-10-09
Websiteshattucklabs.com
500 West 5th Street
Austin, TX 78701
US
Austin, TX 78701
US
512 900 4690
About Shattuck Labs, Inc.
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
Latest News
Shattuck Labs, Inc. (NASDAQ:STTK) Stock Has Consensus Target Price of $13.70 According to Analysts
Nektar, Protagonist, Shattuck are Leerink top picks in emerging immunology
Shattuck Labs (NASDAQ:STTK) Stock Falls 5.3% – Should You Sell?
Shattuck Labs (NASDAQ:STTK) Shares Climb 11.9% – Here’s Why
Shattuck Labs, Inc. (NASDAQ:STTK) Stock Has Consensus Price Target of $12.78 According to Analysts
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Shukla Abhinav A. | M-Exempt | 12,153 | $3.57 | 2026-07-06 |
| Shukla Abhinav A. | M-Exempt | 12,153 | $3.57 | 2026-07-06 |
| Shukla Abhinav A. | M-Exempt | 410 | $3.57 | 2026-07-02 |
| Shukla Abhinav A. | S-Sale | 410 | $7.01 | 2026-07-02 |
| Shukla Abhinav A. | M-Exempt | 410 | $3.57 | 2026-07-02 |